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Glomerular podocytes are critical for the barrier function of the glomerulus in the kidney and their dysfunction causes
protein leakage into the urine (proteinuria). Nephrin is a key podocyte protein, which regulates the actin cytoskeleton via
tyrosine phosphorylation of its cytoplasmic domain. Here we report that two protein tyrosine phosphatases, PTP1B and PTP-
PEST negatively regulate nephrin tyrosine phosphorylation. PTP1B directly binds to and dephosphorylates nephrin, while the
action of PTP-PEST is indirect. The two phosphatases are also upregulated in the glomerulus in the rat model of puromycin
aminonucleoside nephrosis. Both overexpression and inhibition of PTP1B deranged the actin cytoskeleton in cultured mouse
podocytes. Thus, protein tyrosine phosphatases may aﬀect podocyte function via regulating nephrin tyrosine phosphorylation.
1.Introduction
The glomerulus is the ﬁltration unit of the kidney. When
glomerular permselectivity (barrier function) is impaired,
proteinuria occurs, which is a hallmark of many kidney dis-
eases and a major contributing factor to the deterioration of
kidney function. Visceral glomerular epithelial cells (com-
monly known as podocytes) are critical for structural
integrity as well as permselectivity of the glomerulus.
Nephrin (encoded by NPHS1) is a transmembrane protein
expressed in podocytes and its mutations cause severe
congenital nephrotic syndrome and renal failure known
as Finnish type nephrotic syndrome [1]. The cytoplasmic
domain of human nephrin contains 10 tyrosine (Y) residues,
of which 7 are conserved in mouse and rat [2]. Some of
these tyrosine residues are phosphorylated by Src-family
kinases [3, 4]. Phosphorylation of human Y1176, 1193,
and 1217 results in the recruitment of the adaptor protein,
Nck, leading to a localized actin polymerization. The cor-
responding residues have the same role in mouse and rat,
except that Y1176 is missing in rat (Figure 1)[ 2, 5, 6]. We
have previously developed phospho-speciﬁc antibodies for
the Nck-binding phosphotyrosine (pY) residues in human
nephrin [7], which we also validated for rat (Figure 1). Actin
polymerization induced by nephrin-Nck interaction leads
to cellular process formation and morphological changes of
the cell [5]. We [5, 8] and others [9] showed that neph-
rin tyrosine phosphorylation is signiﬁcantly reduced in pur-
omycin aminonucleoside nephrosis (PAN), a rat model of
human minimal change disease and focal segmental glom-
erulosclerosis. Decreased nephrin tyrosine phosphorylation
was accompanied by a decrease in F-actin in glomeruli
[9]. More interestingly, Uchida et al. reported recently
that phosphorylation of the two Nck binding sites (Y1193
and Y1217) is decreased in minimal change disease in
humans [9]. Taken together, nephrin protein complex is
a signaling nexus in podocytes wherein nephrin tyrosine
phosphorylation appears to play a signiﬁcant role in regu-
lating actin cytoskeleton dynamics. However, little is known
about how nephrin tyrosine phosphorylation is regulated. In
particular,itisentirelyunknownwhichphosphatase(s)is/are
responsible for nephrin dephosphorylation.2 Journal of Signal Transduction
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Figure 1: Nck-binding pY residues in human, mouse, and rat nephrin; validation of the phospho-speciﬁc antibodies with rat nephrin. In
the cytoplasmic domain of rat nephrin, two tyrosine residues, Y1204 and Y1228, are responsible for Nck binding when phosphorylated [5].
The third Nck binding site (Y1176 in human and Y1191 in mouse) [2, 6] is absent in rat. Phospho-speciﬁc antibodies developed against
the three Nck-binding sites in human [7] were tested against rat nephrin using Cos-1 cells transiently transfected with wild-type or mutant
rat nephrin and fyn. pY1204r was recognized by both pY1176h and pY1193h antibodies, while pY1228r was recognized by only pY1217h
antibody. Y2F: Y1204/1228F. Nephrin runs as a doublet (180/170kDa) and p-nephrin corresponds to the upper band [3].
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Figure 2: PTP1B, PTP-PEST, and SHP2 are expressed in cultured
mouse podocytes. Immortalized mouse podocytes were either un-
diﬀerentiated or diﬀerentiated for 1-2 wks and cell lysates were
analyzed by immunoblotting to conﬁrm the expression of the three
PTP.
Protein tyrosine phosphatases (PTPs) are deﬁned by the
active-site signature motif HCX5R. After the completion
of the sequence of the human genome, approximately 100
PTPs are recognized in humans, of which 37 are known
as classical phosphotyrosine-speciﬁc PTP [10]. There is a
paucity of data regarding the expression and role of PTP in
podocytes. The only well-characterized PTP that is expressed
highly in podocytes is GLEPP1 [11, 12]. GLEPP1 is a trans-
membrane PTP which localizes in the apical membrane of
podocytes (facing the Bowman’s capsule), and GLEPP1
knockout mice display abnormal podocyte morphology
and increased blood pressure after uninephrectomy [13].
Glombase analysis (large-scale gene identiﬁcation in human
glomerulus [14]) reveals 49 genes enriched in podocytes,
which include only one PTP (GLEPP1). A separate study
investigated the expression proﬁle of PTP by RT-PCR in
cultured mouse podocytes and demonstrated the expression
of SHP2, PTP1B, PTP-PEST, and PTPD2 (formally known
as PTP36) but not SHP1 or PTP20 [15]. Of interest, in
this report, it was demonstrated that the nonspeciﬁc PTP
inhibitor, sodium vanadate, causes dramatic morphological
changes of cultured mouse podocytes, suggesting that PTP
may have an important role in the cytoskeletal regulation of
podocytes [15]. Since the expression of PTP in podocytes has
not been studied systematically, it is possible that other PTP
may also have a role in podocyte function.
The aim of the current study was to identify PTPs which
dephosphorylate nephrin. Since GLEPP1 is localized in the
apical membrane of podocytes, while nephrin is in the slit
diaphragmclosetothebasolateralside,wefocusedourinitial
eﬀort on other PTP, namely PTP1B, PTP-PEST, and SHP2,
whose mRNA expression was previously shown in cultured
podocytes [15].Journal of Signal Transduction 3
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Figure 3: PTP1B and PTP-PEST, but not SHP2, inhibit fyn-induced nephrin phosphorylation. Cos-1 cells were transiently transfected
with the indicated plasmids and cell lysates were analyzed after 24hrs by immunoprecipitation/immunoblotting. When expressed alone,
tyrosine phosphorylation of nephrin was weak, which was markedly increased by fyn. PTP1B and PTP-PEST inhibited fyn-induced tyrosine
phosphorylation of nephrin, while SHP2 did not have any impact. TL: total lysates. PTP1B and PEP-PEST were tagged with GST. WT
indicates wild type. DA and CS indicate substrate trapping (catalytically inactive) mutants of PTP1B and PTP-PEST, respectively (see
Section 2).
2.MaterialsandMethods
2.1. Materials. pEBG-PTP1B-WT and D181A [16], pEBG-
PTP-PEST-WT, and C231S [17] were from Dr. Tremblay
(McGill University). Wild-type PTP1B, which is tagged
with green ﬂuorescent protein (GFP-PTP1B-WT), was from
Dr. Arregui (Universidad de San Mart´ ın, Buenos Aires, Ar-
gentina) [18]. Fyn and rat nephrin plasmids were described
previously [3]. Antibodies were purchased from the fol-
lowing sources: PTP1B and SHP2 (BD Biosciences), PTP-
PEST (Cell Signaling), α-tubulin (Abcam), 4G10 (for
pY, Millipore), GST and fyn (Santa Cruz Biotech.),
pY418-Src (Invitrogen). Antinephrin antibody [3]a n d
phosphospeciﬁc nephrin antibodies [7]w e r ed e s c r i b e d
previously.PTP1BinhibitorwasfromCalbiochem(#539741:
3-(3,5-dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-
sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide).
2.2. Cells. Immortalized cultured mouse podocytes stably
expressing rat nephrin were described previously [19]. These
cells were maintained in permissive conditions at 33◦Ca n d
were diﬀerentiated by a temperature switch to 37◦Cf o r7 –
14 days [19]. Cos-1 cells were cultured in DMEM-10% FBS.
Transient transfection and immunoﬂuorescence staining
were carried out as described previously [19].
2.3. GST Pulldown. Cos-1 cells were transfected with pEBG-
PTP1B or pEBG-PTP-PEST (encoding GST-tagged PTP)
with nephrin. On the following day, cells were lysed in lysis
buﬀer (25mM HEPES (pH 7.5), 1% TritonX-100, 10mM
MgCl2,1 0 0m MN a C l ,5 %g l y c e r o l ,5m MN a F ,1m MP M S F ,
10μg/mL aprotinin, 10μg/mL leupeptin). Equal amounts
of protein (250μg) were incubated for 2h at 4◦Cw i t h
glutathione-sepharose beads. The beads were washed twice
and were subjected to SDS-PAGE and immunoblotting.4 Journal of Signal Transduction
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Figure 4: PTP1B binds to and dephosphorylates nephrin. (a) Cos-1 cells were transiently transfected with nephrin and GST-PTP1B-WT
or GST-PTP1B-DA (substrate-trapping mutant). Cell lysates were subjected to pull-down (PD) with glutathione beads and analyzed by
immunoblotting. PTP1B-DA, but not WT, pulled down nephrin while preserving its phosphorylation. Nephrin pulled down by PTP1B-
DA appeared as a doublet and both bands were phosphorylated—the bottom band corresponded to nephrin at 180kDa, while the top
band (indicated by ∗) ran above 180kDa, possibly representing a hyperphosphorylated form. (b) Pull-down by PTP1B-DA was performed
using Y-to-F mutants of nephrin. Mutation of the two Nck binding sites in rat (Y1204 and Y1228) [5] additively aﬀected nephrin-PTP1B
interaction, while mutation of another Y residue (Y1152, phosphoinositide-3 kinase binding site) [8] had no eﬀect. Densitometric analysis,
normalized to total nephrin, is shown. ∗P<0.05 versus WT, n = 4. (c) Undiﬀerentiated cultured mouse podocytes were serum starved in
0.5% FBS overnight and were incubated with the PTP1B inhibitor (50μM) or vehicle for the indicated times. Cell lysates were analyzed by
immunoblotting for pY1217h (=pY1228r)-nephrin and total nephrin. Bottom: densitometric analysis is shown. Results were normalized to
total nephrin. ∗P<0.05 versus no inhibitor, n = 4.
2.4. qPCR. Total RNA was prepared from glomeruli using
Trizol Reagent (Invitrogen). cDNA synthesis was performed
using a QuantiTect Reverse Transcription kit (Qiagen,
Mississauga, ON). The PCR primer sets used were as
follows: PTP1B fwd: 5 -ggaactgggcggctatttacc-3 ,
rev: 5 - caaaagggctgacatctcggt-3 ;P T P - P E S Tf w d :5  -
gtcgagaatttgagatgggaagg-3 , rev: 5-gtcgagaatttgagatgggaagg-
3 . qPCR was carried out with iTaq SYBR Green supermix
with ROX (Biorad) and an ABI 7300 System (Applied
Biosystems) using the delta Ct method with GAPDH as an
endogenous control.
2.5. Puromycin Aminonucleoside Nephrosis (PAN) and Iso-
lation of Rat Glomeruli. PAN was induced with a sin-
gle intravenous injection of puromycin aminonucleosideJournal of Signal Transduction 5
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Figure5:PTP-PESTdecreasesnephrinphosphorylationviaSrc-familykinase.(a)Pull-downwasperformedasinFigure 4(a)withadditional
plasmids of GST-PTP-PEST-WT and GST-PTP-PEST-CS (substrate-trapping mutant). The substrate-trapping mutant of PTP1B, but not
of PTP-PEST, pulled down nephrin. (b) Cos-1 cells were transiently cotransfected with pEBG (empty vector), GST-PTP-PEST-WT, or
GST-PTP-PEST-CS (substrate trapping mutant) and fyn. After 24hrs, cell lysates were subjected to GST pull down as in Figure 4(a) or
to immunoprecipitation for fyn. Only the substrate-trapping mutant of PTP-PEST (CS), but not the wild-type, pulled down fyn or was
coimmunoprecipitated with fyn. fyn, which was pulled down by PTP-PEST-CS, was strongly phosphorylated at pY418, suggesting that
pY418 containing region is the substrate of PTP-PEST. Wild-type PTP-PEST decreased pY418-Src in total lysates. Note that pY418 antibody
cross-reacts to all the Src-family kinases.
(Sigma-Aldrich Canada, Mississauga, ON, 50mg per kg)
in male Sprague-Dawley rats (150–175g), as previously
described [8]. Isolation of rat glomeruli was performed
by diﬀerential sieving and lysates were prepared in buﬀer
containing 1% Triton X-100, as described previously [8].
Studies were approved by the Animal Care Committee at
McGill University.
2.6. Immunohistochemistry. Immunohistochemistry of rat
kidney sections was performed as described previously [20].
Primary antibodies used were rabbit anti-PTP-PEST anti-
serum (gift from Dr. Michael Tremblay, McGill University,
1:100) [21] and rabbit anti-PTP1B monoclonal antibody
(Epitomics, 1:50).
2.7. Statistics. Data are presented as mean ± SEM. One-
way analysis of variance (ANOVA) was used to determine
signiﬁcant diﬀerences among groups and where signiﬁcant
diﬀerences were found, individual comparisons were made
between groups using the t statistic and adjusting the critical
value according to the Bonferroni method.
3. Results and Discussion
3.1. PTP1B, PTP-PEST, and SHP2 Are Expressed in Cultured
Mouse Podocytes. We ﬁrst studied the expression of the
three well-studied classicalPTPs,namely, PTP1B,PTP-PEST,6 Journal of Signal Transduction
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Figure 6: Both overexpression and inhibition of PTP1B cause deranged actin cytoskeleton and cell morphology in podocytes. (a) Mouse
podocytes were diﬀerentiated for 10 days and were transfected with GFP alone or GFP-PTP1B-WT. On the following day, cells were ﬁxed,
permeabilised, and stained with phalloidin to visualize F-actin. GFP transfected cells (A) or untransfected cells (C, arrow) showed well-
deﬁned stress ﬁbers, as reported previously. Cells transfected with GFP-PTP1B-WT (C, left) showed less stress ﬁbers and ﬁne aggregates
of F-actin. (b) Mouse podocytes were diﬀerentiated for 10 days in the presence or absence of the PTP1B inhibitor (50μM, IC50: 4–8μM,
see Section 2). The inhibitor caused marked morphological changes with smaller cell size, collapsed appearance of cellular processes, and
elongated cell shape, although the stress ﬁbers were well preserved.
and SHP2 in cultured mouse podocytes. By immunoblot-
ting, these three PTPs were clearly expressed in both un-
diﬀerentiatedanddiﬀerentiated mousepodocytes at thepro-
tein level, consistent with the previous report which showed
mRNA expression of these PTP by RT-PCR (Figure 2).
Glomerular expression of the three PTPs has also been
demonstrated by immunohistochemistry in normal human
kidney(HumanProteinAtlas,http://www.proteinatlas.org/).
3.2. PTP1B and PTP-PEST, but Not SHP2, Inhibit Fyn-
Induced Nephrin Tyrosine Phosphorylation. We and others
showedpreviouslythatthecytoplasmicdomainofnephrinis
tyrosine phosphorylated by Src-family kinases, preferentially
by fyn [3, 4]. We thus studied whether the three PTPs
aﬀect fyn-induced nephrin phosphorylation. When nephrin
alone was transiently expressed in Cos-1 cells, its tyrosine
phosphorylation was barely detectable by immunoblotting,
which was markedly increased by coexpression of fyn
(Figure 3). Fyn-induced phosphorylation of nephrin was
almost completely abolished by co-expressing PTP1B or
PTP-PEST but was unaﬀected by SHP2 or catalytically
inactive mutants of PTP1B and PTP-PEST (Figure 3). Thus,Journal of Signal Transduction 7
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Figure 7: PTP1B and PTP-PEST are upregulated in glomeruli of rats with PAN. PAN was induced and glomeruli were isolated by diﬀerential
sieving as in Section 2. (a) mRNA expression of PTP1B and PTP-PEST was quantiﬁed by qPCR. ∗P<0.05 versus control, n = 8r a t sf o r
PTP1Bandn = 6ratsforPTP-PEST.(b)Glomerularlysateswereanalyzedinduplicatebyimmunoblotting.BothPTP1BandPTP-PESTwere
upregulated in a similar time course to the respective mRNAs. Values for proteinuria are mean ± SEM of 4 rats. Lower panel: densitometric
analysis for PTP1B (N = 6 rats) and PTP-PEST (N = 4 rats) proteins. ∗P<0.05, ∗∗P<0.01 versus control (c) Immunohistochemistry of
control and PAN-treated rat kidneys. In normal rat glomeruli, weak PTP1B and PTP-PEST expression was detected with some staining in
the extracapillary location compatible with podocytes (arrows). In the kidney from PAN rats, expression of the two PTP was upregulated, in
particular in podocytes (arrowheads, day 7 for PTP1B and day 14 for PTP-PEST). There was no staining when the primary antibodies were
replaced with control IgG (not shown).
PTP1B and PTP-PEST, but not SHP2, are likely to contribute
to dephosphorylation of nephrin.
3.3. PTP1B Directly Binds to and Dephosphorylates Nephrin.
We next asked if PTP1B dephosphorylates nephrin directly.
TheD181AmutantofPTP1B(PTP1B-DA)retainstheability
tobindtopYcontainingsubstratesbutlacksthephosphatase
activity and is called “substrate-trapping mutant” [16]. A
substrate-trapping mutant can form stable complex with
the substrates and can be used to pull down bound
substrates. Since pY residues are protected from endogenous
phosphatases by substrate trapping mutants, substrates are
typically hyperphosphorylated in the presence of substrate
trapping mutants. When transfected in Cos-1 cells, PTP1B-
DA pulled down nephrin eﬀectively, while wild-type PTP1B
did not (Figure 4(a)). Nephrin, which was pulled down by
PTP1B-DA was strongly phosphorylated, consistent with the
ability of the substrate-trapping mutants to bind to and
protect pY from endogenous phosphatases (Figure 4(a)).
TheabilityofPTP1B-DAtopulldownnephrinwasmarkedly
impaired when the Nck-binding tyrosine residues, Y1204
or Y1228 in rat, were mutated to phenylalanine and
was virtually abolished when both residues were mutated
simultaneously (Figure 4(b)). In contrast, mutation of the
phosphoinositide-3 kinase binding site, Y1152 (rat), did not
aﬀect nephrin-PTP1B-DA interaction (Figure 4(b)). Finally,
when mouse podocytes stably overexpressing rat nephrin
were incubated with a speciﬁc PTP1B inhibitor for one hour,
phosphorylation of Y1228 (rat) was augmented signiﬁcantly
(Figure 4(c)). Taken together, we conclude that PTP1B
directly binds to and dephosphorylates the Nck-binding sites
(pY1204 and pY1228) of rat nephrin.
3.4. PTP-PEST Decreases Nephrin Phosphorylation Indirectly.
We next studied nephrin-PTP-PEST interaction using a
similar strategy.IncontrasttoPTP1B,thesubstrate-trappingJournal of Signal Transduction 9
mutant of PTP-PEST, PTP-PEST-C231S [17], failed to pull
down nephrin in Cos-1 cells, indicating that nephrin is not
a direct substrate of PTP-PEST (Figure 5). It was reported
previously that the activity of the Src-family kinases could
be regulated by PTP [22–24]. Thus, we next studied if
fyn phosphorylation and activity were aﬀected by PTP-
PEST. It is established that phosphorylation at Y418 in the
catalyticsiteiscriticalfortheactivationofSrc-familykinases,
and thus, is used as a marker of activation [25]. When
transfected in Cos-1 cells, PTP-PEST (wild type) decreased
the phosphorylation of Y418 (Figure 5(b)-right, 2nd panel).
The substrate trapping mutant, PTP-PEST-CS, but not the
wildtype,pulleddownfyn(Figure 5(b)-left,1stpanel)which
was strongly phosphorylated onY418 (Figure 5(b)-left, 2nd
panel). Similarly, the substrate trapping mutant of PTP-
PEST but not the wild type coimmunoprecipitated with fyn
(Figure 5(b)-lower panels). These results suggest that PTP-
PEST binds to and dephosphorylates fyn at Y418, thereby
inhibiting its activity. Inhibition of fyn in turn is likely to
contribute to reduced phosphorylation of nephrin.
3.5. Both Overexpression and Inhibition of PTP1B Cause De-
ranged Actin Cytoskeleton and Cell Morphology in Podocytes.
In order to address the function of PTP1B in podocytes, we
next overexpressed wild-type PTP1B tagged with GFP in dif-
ferentiated mouse podocytes (Figure 6(a)). GFP transfected
cells (Figure 6(a)-(A)) or untransfected cells (Figure 6(a)-
(C), arrow) showed well-deﬁned stress ﬁbers, as reported
previously [19]. By contrast, GFP-PTP1B-WT showed gran-
ular distribution, similar to the previous report [18]. Cells
transfected with GFP-PTP1B-WT (Figure 6(a)-(C), left)
showed less stress ﬁbers and ﬁne aggregates of F-actin. We
next examined diﬀerentiated mouse podocytes cultured in
thepresenceorabsenceofthePTP1Binhibitor(Figure 6(b)).
The inhibitor caused marked morphological changes with
smaller cell size, collapsed appearance of cellular processes,
and elongated cell shape, although the stress ﬁbers were well
preserved. These results suggest that the appropriate amount
of PTP1B is necessary to maintain normal cell structure of
podocytes.
3.6. Glomerular PTP1B and PTP-PEST Are Upregulated in
the Rat Model of Proteinuria. Puromycin aminonucleoside
nephrosis (PAN) is a rat model of podocyte injury and
proteinuria and is widely accepted as a model of minimal
change disease or focal segmental glomerulosclerosis in
humans [26]. We and others reported previously that
tyrosine phosphorylation of nephrin at the Nck-binding
sites,thatis,Y1204andY1228inratisdecreasedsigniﬁcantly
in this model [7–9]. Since PTP1B and PTP-PEST decreased
nephrin phosphorylation in vitro, we next studied the
expression level of these two PTPs in glomeruli of rats
with PAN. In this model of podocyte injury, proteinuria
typically starts on day 4, peaks on day 7, and starts to
decline on day 14 after disease induction, while decrease of
nephrin tyrosine phosphorylation is observed starting on
day 4 and persisting until day 14 [7]. By qPCR, PTP1B
mRNA was signiﬁcantly upregulated on days 7 and 14,
while upregulation of PTP-PEST mRNA was signiﬁcant only
on day 14 (Figure 7(a)). Immunoblotting showed protein
upregulation of these two PTP in the time course similar
to respective mRNAs (Figure 7(b)). Furthermore, increased
expression of PTP1B and PTP-PEST could also be seen in
podocytes of kidney sections obtained from PAN-treated
rats when compared to normal control rats (Figure 7(c)).
Upregulationoftheproteinsweremoredistinct,ascompared
with that of mRNAs, suggesting that there may be post-
translational modiﬁcation, in addition to transcriptional or
posttranscriptional regulations of the mRNAs (Figure 7(b)).
Although causal relationship cannot be established, these
results are consistent with the notion that upregulation of
PTP1B and PTP-PEST contributes to decreased tyrosine
phosphorylation of nephrin, which may in turn result in
impaired cytoskeletal regulation in podocytes and develop-
ment of proteinuria.
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